Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0028 | 0.0414 | 1 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0028 | 0.0414 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0265 | 0.9707 | 0.981 |
Brugia malayi | hypothetical protein | 0.0028 | 0.0414 | 0.0414 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0028 | 0.0414 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0134 | 0.4558 | 0.4606 |
Echinococcus granulosus | jun protein | 0.0272 | 1 | 1 |
Echinococcus multilocularis | geminin | 0.019 | 0.6761 | 0.6761 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0028 | 0.0414 | 1 |
Brugia malayi | hypothetical protein | 0.004 | 0.0888 | 0.0888 |
Schistosoma mansoni | hypothetical protein | 0.019 | 0.6761 | 0.8455 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0028 | 0.0414 | 1 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.004 | 0.0888 | 0.111 |
Schistosoma mansoni | hypothetical protein | 0.0221 | 0.7996 | 1 |
Brugia malayi | hypothetical protein | 0.0018 | 0.0021 | 0.0021 |
Brugia malayi | Pax transcription factor protein 2 | 0.0269 | 0.9895 | 0.9895 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.0414 | 0.0418 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0134 | 0.4558 | 0.4606 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.004 | 0.0888 | 0.0888 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription factor | 0.0272 | 1 | 1 |
Loa Loa (eye worm) | pax transcription factor protein 2 | 0.0269 | 0.9895 | 1 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0.0888 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0028 | 0.0414 | 1 |
Schistosoma mansoni | jun-related protein | 0.0221 | 0.7996 | 1 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0.0888 | 0.5 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription factor | 0.0272 | 1 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0134 | 0.4558 | 0.4558 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0018 | 0 | 0.5 |
Brugia malayi | hypothetical protein | 0.0214 | 0.7703 | 0.7703 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.004 | 0.0888 | 0.0888 |
Echinococcus granulosus | geminin | 0.019 | 0.6761 | 0.6761 |
Onchocerca volvulus | 0.0269 | 0.9895 | 1 | |
Echinococcus multilocularis | jun protein | 0.0272 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.004 | 0.0888 | 0.111 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0.0888 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0.0888 | 0.5 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0028 | 0.0414 | 1 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0028 | 0.0414 | 1 |
Schistosoma mansoni | hypothetical protein | 0.019 | 0.6761 | 0.8455 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Cytotoxicity (functional) | = 0.037 uM | In vitro cytotoxicity of compound was determined against CH1 (cisplatin resistant) cell lines at 37 degree C after 96 hr | ChEMBL. | 10969983 |
Cytotoxicity (functional) | = 0.037 uM | In vitro cytotoxicity of compound was determined against CH1 (cisplatin resistant) cell lines at 37 degree C after 96 hr | ChEMBL. | 10969983 |
Cytotoxicity (functional) | = 0.07 uM | In vitro cytotoxicity of compound was determined against A2780 cell lines at 37 degree C after 96 hr | ChEMBL. | 10969983 |
Cytotoxicity (functional) | = 0.07 uM | In vitro cytotoxicity of compound was determined against A2780 cell lines at 37 degree C after 96 hr | ChEMBL. | 10969983 |
Cytotoxicity (functional) | = 0.09 uM | In vitro cytotoxicity of compound was determined against CH1 cell lines at 37 degree C after 96 hr | ChEMBL. | 10969983 |
Cytotoxicity (functional) | = 0.09 uM | In vitro cytotoxicity of compound was determined against CH1 cell lines at 37 degree C after 96 hr | ChEMBL. | 10969983 |
Cytotoxicity (functional) | = 0.105 uM | In vitro cytotoxicity of compound was determined against SKOV-3 cell lines at 37 degree C after 96 hr | ChEMBL. | 10969983 |
Cytotoxicity (functional) | = 0.105 uM | In vitro cytotoxicity of compound was determined against A2780 cell lines (cisplatin resistant) at 37 degree C after 96 hr | ChEMBL. | 10969983 |
Cytotoxicity (functional) | = 0.105 uM | In vitro cytotoxicity of compound was determined against SKOV-3 cell lines at 37 degree C after 96 hr | ChEMBL. | 10969983 |
Cytotoxicity (functional) | = 0.105 uM | In vitro cytotoxicity of compound was determined against A2780 cell lines (cisplatin resistant) at 37 degree C after 96 hr | ChEMBL. | 10969983 |
Delta Tm (functional) | = 3.98 degrees C | Change in temperature (thermal denaturation) was determined from calf thymus DNA at 37 degree centigrade for 0 hours | ChEMBL. | 10969983 |
Delta Tm (functional) | = 4.61 degrees C | Change in temperature (thermal denaturation) was determined from calf thymus DNA at 37 degree centigrade for 4 hours | ChEMBL. | 10969983 |
Delta Tm (functional) | = 5.6 degrees C | Change in temperature (thermal denaturation) was determined from calf thymus DNA at 37 degree centigrade for 18 hours | ChEMBL. | 10969983 |
Resistance factor (functional) | = 0.4 | Resistance factor of compound was determined from cisplatin resistant CH1 cell lines to that of CH1 cell lines | ChEMBL. | 10969983 |
Resistance factor (functional) | = 1.5 | Resistance factor of compound was determined from cisplatin resistant A2780 cell lines to that of A2780 cell lines | ChEMBL. | 10969983 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.